4
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Management of intra-uterine fetal death with vaginal administration of gemeprost or prostaglandin E2: A random allocation controlled trial

, , &
Pages 422-426 | Published online: 02 Jul 2009

References

  • Cabrol D., D'Yvoire B. M., Mermet E., Cedard L., Sureau C., Baulieu E. E. Induction of labour with mifepristone after intra‐uterine fetal death. Lancet 1985; 330: 1019
  • Calder A. A., MacKenzie I. Z., Embrey M. P. Intra‐uterine (extra‐amniotic) prostaglandins in the management of unsuccessful pregnancy. Journal of Reproductive Medicine 1976; 16: 271–275
  • Claman P., Carpenter R. J., Reiter A. Uterine rupture with the use of vaginal prostaglandin E., for induction of labour. American Journal of Obstetrics and Gynecology 1984; 150: 889–891
  • Csapo A. I. The ‘see‐saw’ theory of parturition. Ciba Foundation Symposia 1977; 47: 159–210
  • Embrey M. P., Calder A. A., Hillier K. Extra amniotic prostaglandins in the management of intrauterine fetal death, anencephaly and hydatidiform mole. Journal of Obstetrics and Gynaecology of the British Commonwealth 1974; 81: 47–51
  • Garcea N., Dargenio R., Panetta V., Moneta E., Tan‐credi G., Giannitelli A. A prostaglandin analogue (ONO‐802) in treatment of missed abortion. intrauterine fetal death and hydatidiform mole: a dose finding trial. European Journal of Obstetrics. Gynecology and Reproductive Biology 1987; 25: 15–22
  • Grandin D. J., Hall R. E. Fetal death before the onset of labour. An analysis of 407 cases. American Journal of Obstetrics and Gynecology 1960; 79: 237–243
  • Hill N. C. W., Selinger M., Ferguson J., Lopez Bernal A., Mackenzie I. Z. The physiological and clinical effects of progesterone inhibition with mifepristone in the second trimester. British Journal of Obstetrics and Gynaecology 1990; 97: 487–492
  • Karim S. M. M., Lim A. L., Prasad R. N. V., Yeo K. C., Ng S. C., Salmon Y. M., Choo H. T., Ratman S. S. Termination of abnormal intrauterine pregancy with intramuscular administration of sulprostone. Singapore Journal of Obstetrics and Gynecology 1979; 10: 33–38
  • Kent D. R., Goldstein A. I., Linzey E. M. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third‐trimester fetal demise. Journal of Reproductive Medicine 1984; 29: 101–102
  • Kochenour N. K. Management of fetal demise. Clinical Obstetrics and Gynecology 1987; 30: 322–330
  • Lauersen N., Wilson K. H. Induction of labour in patients with missed abortion and fetal death in ulero with prostaglandin E2 suppositories. American Journal of Obstetrics and Gynecology 1977; 127: 609–611
  • MacKenzie I. Z., Davies A. J., Embrey M. P. Fetal death in utero managed with vaginal prostaglandin E2 gel. British Medical Journal 1979; i: 1764–1765
  • Padayachi T., Norman R. J., Moodley J., Heyns A. Mifepristone and induction of labour in second half of pregnancy. Lancet 1988; 333: 647
  • Rath W., Kuhn W. Cervical ripening and induction of labour by intracervical and extra‐amniotic prostaglandin gel application in cases of intrauterine fetal death. International Journal of Gynaecology and Obstetrics 1985; 23: 387–394
  • Rutland A., Ballard C. Vaginal prostaglandin E., for missed abortion and intrauterine fetal death. American Journal of Obstetrics and Gynecology 1977; 128: 503–506
  • Sawyer M. M., Lipshitz J., Anderson G. D., Dilts P. V. Third trimester uterine rupture associated with vaginal prostaglandin E2. American Journal of Obstetrics and Gynecology 1981; 140: 710–712
  • Selinger M., MacKenzie I. Z., Gillmer M. D., Phipps S. L., Ferguson J. Progesterone inhibition in mid‐trimester termination of pregnancy: physiological and clinical effects. British Journal of Obstetrics and Gynaecology 1987; 94: 1218–1222
  • Southern E. M., Gutknecht G. D. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories. Obstetrics and Gynecology 1976; 47: 602–606
  • Southern E. M., Gutknecht G. D., Mohberg N. R., Edelman D. A. Vaginal prostaglandin E., in the management of fetal intrauterine death. British Journal of Obstetrics and Gynaecology 1978; 85: 437–441
  • Urquhart D. R., Templeton A. A. Mifepristone (RU 486) and second‐trimester termination. Lancet 1987; 332: 1405
  • Wallenburg H. C. S., Keirse M. J. N. C., Freie H. M. P., Blacquiere J. F. Intramuscular administration of 15(S)‐15‐methyl prostaglandin F., for induction of labour in patients with fetal death. British Journal of Obstetrics and Gynaecology 1980; 87: 203–209
  • Wiley T. L., Poole C. P., Gookin K. S., Wiser W. L., Morrison J. C. Prostaglandin E2 induction of abortion and fetal demise. International Journal of Gynaecology and Obstetrics 1989; 28: 171–175

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.